Assessing the Effectiveness of a CBT-based App in Reducing Suicidal Ideation
Suicide Ideation
About this trial
This is an interventional treatment trial for Suicide Ideation focused on measuring Suicide ideation, Mental pain, Mobile app, Application
Eligibility Criteria
Inclusion Criteria:
- Hebrew speakers
- Subjects at a low suicide risk only (see note below).
- Patients who suffered from passive suicide ideation in the past two weeks.
- Participants must have a mobile phone capable of supporting the GGSI app.
Exclusion Criteria:
- Patients at moderate to high suicide risk, as determined by The Columbia- Suicide Severity Rating Scale (C-SSRC; Posner et al., 2011)
- Patients diagnosed with psychosis or autism, and drug users.
Patients who are admitted to the ER, or are hospitalized in the psychiatric wards.
- Suicide risk will be determined by The Columbia- Suicide Severity Rating Scale (C-SSRC; Posner et al., 2011). In accordance with this scale, we defined at a low suicide risk patients who have suicide ideation but without a method of execution, suicide intention, or suicide plan. At moderate to high suicide risk we defined patients who indorse suicide ideation with a method of execution and\or suicide intention and\or suicide plan.
Sites / Locations
- Emek Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
using app first
waiting list
The experimental group will immediately start using the GGSI app, for a period of 15 days (T1). After 15 days (T2) the experimental group ceases its use of the app. The end of this period is marked T3. The research team will contact the experimental group on T1, T2 and T3 in order to fill out questionnaires regarding suicide ideation and related risk factors.
During the first 15 days, the control group is inactive (T1). After 15 days (T2) the control group will start using GGSI app for additional 15 days (T3). Participants will fill questionnaires about suicide ideation and related risk factors three time during the study on: T1, T2 and T3.